Philips Leads SEISMIC, a Consortium for Minimally Invasive Neurosurgery
Royal Philips announces that the SEISMIC consortium, which it coordinates with Erasmus MC, has secured funding from the Innovative Health Initiative to develop minimally invasive neurosurgery techniques integrated with advanced imaging technologies. The research program will span five years and include eight clinical studies.
The SEISMIC consortium aims to transform neurosurgery by integrating minimally invasive techniques with advanced imaging technologies. The project focuses on three neurological conditions: intracerebral hemorrhage, subdural hematoma, and brain tumors. The initiative plans to develop an integrated technology suite that includes real-time surgical navigation combining ultrasound and radiological imaging, realistic simulation platforms for clinical training, as well as minimally invasive biopsy and treatment techniques. The declared goal is to reduce operation times, minimize surgical trauma, and accelerate patient recovery.
Consortium Structure
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
SEISMIC is structured as a public-private partnership comprising nine medical technology partners, two patient organizations, and seven academic partners. No specific timeline for implementation or intermediate milestones is indicated beyond the overall five-year duration of the program.
SectorSanté · Technologie · Dispositifs médicaux›Équipements Médicaux
Context
Period
Period: 1T2026
Key reported figures
Revenue: 3.9MD€
Free cash flow: 28M€
Guidance from the release
Nous avons délivré un bon départ en 2026.
Bonne performance au T1, croissance des ventes et des marges.
Risks mentioned
Impact des tarifs et inflation des coûts sur les marges.
Environnement macroéconomique incertain impactant les performances.
Opportunities identified
Croissance des ventes comparables de 4% dans tous les segments.
Augmentation du carnet de commandes grâce à des innovations.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
